LYC Healthcare Reports Strong Q3 FY2024 Results of RM36.0 Million
In Q3 FY2024, LYC Healthcare achieved a robust revenue of RM35.9 million, a notable increase from RM23.5 million in the same quarter of the previous year (Q3 FY2023).
- In Q3 FY2024, LYC Healthcare achieved a robust revenue of RM35.9 million, a notable increase from RM23.5 million in the same quarter of the previous year (Q3 FY2023).
- In Singapore, the healthcare operations continued to excel, generating revenue of RM11.9 million and a profit before tax of RM0.8 million.
- Cumulatively, for the nine months ended 31 December 2023 (9M FY2024), LYC Healthcare posted a revenue of RM95.0 million, up from RM66.6 million in the same period last year.
- On a quarter-on-quarter basis, LYC Healthcare's revenue increased from RM32.4 million in the preceding quarter to RM35.9 million, with LBT narrowing to RM1.2 million from RM2.0 million, further evidencing the Group's strong performance momentum.